PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for May 31, 2009 Subscribe to this News Feed    
 

Dermaxin Challenges Botox in the Wrinkle War

The wrinkle war rages on as the behemoth of anti-wrinkle injections, Botox, faces some sordid challenges. A leading anti-wrinkle cream, Dermaxin, offers consumers an alternative to the costly and painful, side effect-ridden injections, promising the consumer instantly-noticeable results of wrinkle depth reduction within the first ten minutes of application. The secret weapon: Acetyl Hexapeptide-8, a powerful, clinically-proven and patented facial-relaxing compound and wrinkle remover.

Manalapan, NJ (PRWEB) May 31, 2009 -- While Botox may be the reining king of the popular facial injections that are lauded for their anti-wrinkle benefits, Dermaxin wrinkle cream is rising to the challenge with a secret weapon of its own: Acetyl Hexapeptide-8. This clinically-proven peptide is similar to Botox in the extent that it is a facial-relaxing compound and wrinkle remover. Acetyl Hexapeptide-8 goes to work immediately to relax muscles in the face that contribute to wrinkles and smile lines, typically showing nearly instant results for users within the first ten minutes of application.

The proprietary ingredient complex in Dermaxin doesn't just rely upon the power of Acetyl Hexapeptide-8 however. Dermaxin also incorporates other clinically-proven ingredients such as Palmitoyl Oligopeptide and Palmitoyl Tetrapeptide-7 (both proven to increase the production of collagen and the growth of the connective tissues).

Inclusive of the Dermaxin formula is the power of natural collagen (not bovine-based like collagen injections), and Retinyl Palmitate, a powerful anti-oxidant. Dermaxin delivers these complexes deeply into the skin using nature's most potent moisturizer, Hyaluronic Acid (a very powerful moisturizer that can carry up to a thousand times its own weight in water).

This proven ingredient complex assures that consumers will be able to wage an effective battle against the aging process in an all-natural manner, and without have to fret over adverse side effects of any kind. In fact, during the clinical trials and testing periods, Dermaxin was clinically-proven to reduce the appearance of fine lines and wrinkles by up to 44% during the first 4-12 weeks of treatment, and to show noticeable signs of wrinkle depth reduction within the first ten minutes of application.

"Dermaxin can easily challenge the offerings of Botox and win every time," states Teresa Richards, spokesperson for Dermestetics (the makers of Dermaxin, distributed online by Healthwebshopping.com).

"By incorporating a variety of patented and clinically-proven anti-aging compounds that are naturally derived, Dermaxin is able to offer instant results for users, but without causing any side effects," Richards says.

Dermaxin wrinkle cream is easily applied to the skin using small dabs and pats of the cream, lightly massaged into the skin. It typically shows instant results of wrinkled depth reduction and smoothing within the first ten minutes of application. Most people will realize an overall wrinkle depth reduction of up to 44% within the first 4-12 weeks of daily usage.

For more information on how Dermaxin wrinkle cream can help you to minimize the appearances of fine lines and wrinkles, and rejuvenate your skin, please visit them online at: http://www.dermaxin.com.

# # #

OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Liz Gilman
Health Web Shopping
(800) 344-0478
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.